In a study published in The Lancet, Cognitive Functional Therapy (CFT) showed significant improvements in chronic back pain sufferers, reducing pain intensity and disability while saving over $5,000 per person in healthcare and work productivity costs. Long-term sufferers of chronic back pain exp
A new treatment for chronic back pain, called Cognitive Functional Therapy , has shown significant improvements in pain intensity and pain-related disability. The whole-person approach was tested on nearly 500 participants, who experienced large, clinically important reductions in pain and disability one year after the treatment.
Retired mathematician Volker Rehbocks, a father of two, had been living with chronic back pain for at least 18 months. His GP told him that his gardening days were over, to avoid bending and lifting, gave him anti-inflammatories and advised him to rest his back. The constant pain and impact on his daily life left him feeling anxious and depressed. Mr. Rehbocks turned to the new treatment for help – and the difference has been life-changing.
Participants living with chronic back pain – including many who had high levels of disability – tested the program in up to seven sessions over a 12-week period, followed by a booster session at six months. They were followed up by questionnaires until 12 months. More than 80 percent of the participants were satisfied with the treatment.
“The main economic efficiency results showed participants who took part in the CFT treatment saved more than $5,000 per person, largely driven by improvements in their productivity in both paid and unpaid work,” Professor Haines said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Apple's Assistive Access simplifies iOS 16 for people with cognitive disabilities | EngadgetApple has announced a raft of new iOS features for cognitive accessibility, along with Live Speech, Personal Voice and more..
Weiterlesen »
Brain imaging: fMRI advances make scans sharper and fasterResearchers are finding ways to improve one of neuroscientists’ favourite tools: functional magnetic resonance imaging.
Weiterlesen »
What the Eyes Can Tell Us About Brain HealthYour eyes may be windows to the soul, but recent research shows they're also windows into the health of your memory and its possible impairment. Here's why.
Weiterlesen »
Harvard Researchers Design “Mini Gene” Therapy for Severe Genetic DiseaseResearchers have developed a 'mini gene' therapy for a debilitating syndrome that results in both blindness and deafness. Usher Syndrome type 1F is a rare, debilitating genetic disorder characterized by deafness, impaired balance, and the gradual deterioration of vision. Now, a team of researche
Weiterlesen »
Episode 1: When Is CAR T-Cell Therapy the Answer?Drs AmeliaLangston and MelodySmithMD provide an overview of CARTcellTherapy, the products available, potential complications, and what's next in this rapidly advancing field. Immunotherapy CancerTreatment
Weiterlesen »
Sarepta stock soars 30% premarket after FDA panel backs accelerated approval for Duchenne muscular dystrophy therapySarepta Therapeutics Inc.’s stock soared 30% premarket Monday, after a U.S. Food and Drug Administration panel voted 8-6 in favor of accelerated approval for...
Weiterlesen »